Deep neural network for cell type differentiation in myelodysplastic syndrome diagnosis performs similarly when trained on compensated or uncompensated data
Jon J. Camp(Mayo Clinic), David Holmes(WinnMed), Dragan Jevremović(Mayo Clinic in Arizona), Horatiu Olteanu(Mayo Clinic in Arizona), Aref Al‐Kali(Mayo Clinic), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Gregory E. Otteson(Mayo Clinic in Arizona), Ahmad Nanaa(Mayo Clinic), Min Shi(Mayo Clinic in Arizona), Jansen N. Seheult(Pediatrics and Genetics)
Cited by 2
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441